Skip to content

The Effect of Kiwi on Blood Pressure, Endothelial Function, Antioxidant Capacity and Gene Expression

The Effect of Kiwi on Blood Pressure, Endothelial Function, Antioxidant Capacity and Gene Expression in Mildly Hypertensive Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00948363
Enrollment
118
Registered
2009-07-29
Start date
2009-08-31
Completion date
2010-12-31
Last updated
2017-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Kiwi fruits, Blood pressure, Endothelial function, Antioxidant capacity

Brief summary

The purpose of this study is to determine whether the intake of kiwi fruits will reduce systolic and diastolic blood pressure compared to intake of apples. The investigators hypothesize that the increased intake lutein or other components in the kiwi fruit will enhance nitric oxide bioavailability and lead to vascular relaxation.

Detailed description

An interesting finding in the Oslo Antioxidant Study was that intake of 3 kiwi fruits reduced blood pressure in a clinical significant manner compared to controls. The mechanism for the blood pressure reducing effect of kiwi or the responsible components are not elucidated. However, plasma lutein levels and antioxidant capacity measured by the ferric reducing antioxidant power was increased in the kiwi group. Moreover, gene expression was also altered by the increased intake of kiwi.

Interventions

OTHERKiwi fruits

Daily intake of 3 kiwi fruits for 8 weeks

OTHERApple

Daily intake of 1 apple (equivalent in energy) for 8 weeks

Sponsors

University of Oslo
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* Systolic blood pressure 130-159 mmHg * Diastolic blood pressure 85-99 mmHg * Body mass index \<35 kg/m2

Exclusion criteria

* Systolic blood pressure \>160 mmHg or \<129 mmHg * Diastolic blood pressure \>100 mmHg or \<84 mmHg * Current use or need for blood pressure lowering medication * Symptomatic cardiovascular disease, diabetes, renal dysfunction, psychiatric disorder, pregnancy or lactation, history of obesity surgery.

Design outcomes

Primary

MeasureTime frame
Blood pressure8 weeks

Secondary

MeasureTime frame
Endothelial function8 weeks

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026